Antinociceptive properties and nitric oxide synthase inhibitory action of new ruthenium complexes

European Journal of Pharmacology

Volumn 369, Issue 3, 1999, Pages 289-297

  Beirith, Alessandra ^a   Creczynski Pasa, Tânia B ^a   Bonetti, Vilson R ^a   Konzen, Marlon ^a   Seifriz, Ilana ^a   Paula, Marcos S ^a   Franco, Cesar V ^a   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antinociception; Blood pressure; Formalin test; Hot plate test; Nitric oxide (NO); Nitric oxide (NO) synthase; Pain; Rota rod test; Ruthenium complex

Indexed keywords

ACETYLCHOLINE; ARGININE; FORMALDEHYDE; ISOENZYME; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RUTHENIUM COMPLEX; TRITIUM;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; AORTA; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME INDUCTION; ENZYME INHIBITION; FEMALE; HOT PLATE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MOTOR ACTIVITY; MOUSE; NERVE CELL; NONHUMAN; PAIN; PRIORITY JOURNAL; RABBIT; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR RING;

EID: 0032891690     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00095-3     Document Type: Article

References (33)

1. Abrams, M.J., 1996. Ruthenium complex scavenging of nitric oxide in biological systems. 31st International Conference on Coordination Chemistry, Abstract 1S1, Aug. 18-23, Vancouver.
2. Beirith A., Santos A.R.S., Rodrigues A.L.S., Creczynski-Pasa T.B., Calixto J.B. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate test. Study of the mechanism of action. Eur. J. Pharmacol. 345:1998;233-245.
3. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685.
4. Brignola G., Calignano A., Di Rosa M. Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br. J. Pharmacol. 113:1994;1372-1376.
5. Calixto J.B., Medeiros Y.S. Effect of protein C and calcium on bradykinin-mediated contraction of rabbit vessels. Hypertension. 19:1992;87-93.
6. Christopherson K.S., Bredt D.S. Nitric oxide in excitable tissues: physiological roles and disease. J. Clin. Invest. 100:1997;2424-2429.
7. Eddy N.B., Leimbach D. Synthetic analgesics: II. Dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107:1953;385-393.
8. 4] complexes (L=Pyridine derived ligands: 3-pyridinecarboxylic acid and 4-pyridinecarboxylic acid). J. Coord. Chem. 46:1998;491-504.
9. Fricker S.P., Slade E., Powell N.A., Vaughan O.J., Henderson G.R., Murrer B.A., Megson I.L., Bisland S.K., Flitney F.W. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases. Br. J. Pharmacol. 122:1997;1441-1449.
10. Fukuto J.M., Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Ann. Rev. Pharmacol. Toxicol. 35:1995;165-194.
11. Gratton J.P., Maurice M.C., Rae G.A., D'Orléans-Juste P. Pharmacological properties of endothelins and big endothelin in ketamine/xylazine or urethane anesthetized rats. Am. J. Hypert. 8:1995;1121-1127.
12. Handy R.L.C., Wallace P., Gaffen Z.A., Whitehead K.J., Moore P.K. The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br. J. Pharmacol. 116:1995;2349-2350.
13. Heijden, M., Van Vliet, P.M., Haasnoot, G., Reedjik, J., 1993. Synthesis and characterisation of cis-(2,2′-Bipyridine) (2,2′-biquinoline) dichlroruthenium (II) and its co-ordination chemistry with imidazole derivatives. J. Chem. Soc. Dalton Trans., 3675-3679.
14. Kerwin J.F., Lancaster J.R., Feldman P.L. Nitric oxide: a new paradigm for second messenger. J. Med. Chem. 38:1995;4343-4362.
15. Knowles R.G., Palacios R.M.J., Palmer R.M.J., Moncada S. Kinetic characteristics of nitric synthase from rat brain. Biochem. J. 269:1990;207-210.
16. Kobzik L., Reid M.B., Bredt D.S., Stamler J.S. Nitric oxide in skeletal muscle. Nature. 372:1994;546-548.
17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
18. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain. 54:1993;291-300.
19. Marletta M.A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell. 78:1994;927-930.
20. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
21. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience. 60:1994;367-374.
22. Misko T.P., Moore W.M., Katen T.P., Nickols G.A., Cobert J.A., Tilton R.G., McDaniel M.L., Willamson J.R., Currie M.G. Selective inhibition of the nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 223:1993;119-125.
23. G-nitroarginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102:1991;198-202.
24. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993;219-224.
25. Nakane M., Schmidt H.H., Pollock J.S., Forstermann U., Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 316:1993;175-180.
26. Quinn A.C., Petros A.J., Wallance P. Nitric oxide: an endogenous gas. Br. J. Anaest. 74:1995;443-451.
27. Rees D.D., Palmer R.M.J., Schultz R., Hodson H.F., Moncada S. Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
28. Rosland J.H., Hunskaar S., Hole K. Diazepam attenuates morphine antinociception test-dependently in mice. Pharmacol. Toxicol. 66:1990;382-386.
29. Sessa W.C., Harrisson J.K., Luthin D.R., Pollock J.S., Lynch K.R. Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase. Hypertension. 21:1993;934-938.
30. Southan G.J., Zsabo C., Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol. 114:1995;510-516.
31. Vaz Z.R., Cechinel Filho V., Yunes R.A., Calixto J.B. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative, on chemical and thermal models of nociception in mice. J. Phamacol. Exp. Ther. 278:1996;304-312.
32. Wolff D.J., Datto G.A. Identification and characterisation of a calmodulin-dependent nitric oxide synthase from GH3 pituitary cells. Biochem. J. 285:1992;201-205.
33. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.